DBV Technologies S.A. Stock News

Aimmune Therapeutics Inc. is navigating a host of new challenges as it launches Palforzia, the first peanut allergy immunotherapy to be approved by the US

Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak Citi PTCT SRPT IONS HALO MIRM DBVT SNDX NERV XFOR MLND CBAY

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares climbed 431% to close at $18.00 on Friday after the company reported that the FDA granted emergency expanded access...

Montrouge, France, March 20, 2020 DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F DBV Technologies (Euronext:.

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares jumped 549% to $22.00 after the company reported that the FDA granted emergency expanded access for INOpulse for the...

Gainers Rand Capital Corporation (NASDAQ: RAND) shares rose 114.8% to $5.24 in pre-market trading after the company announced its portfolio company, Rhoenix, is launching...

Gainers Guess?, Inc. (NYSE: GES) shares jumped 124.5% to close at $8.80 on Thursday after the company reported better-than-expected Q4 earnings. Designer Brands Inc. (NYSE: DBI)...

Gainers Guess?, Inc. (NYSE: GES) rose 91.3% to $7.50 after the company reported better-than-expected Q4 earnings. Chanticleer Holdings, Inc. (NASDAQ: BURG) shares jumped 74.3% to...

Waitr Holdings (NASDAQ:WTRH) +70% as few consumer stocks are performing well during the rough road ahead.iFresh (NASDAQ:IFMK) +56%.Biomerica (NASDAQ:BMRA) +52% on advancement of rapid coronavirus te

Gainers Chanticleer Holdings, Inc. (NASDAQ: BURG) shares rose 117.1% to $1.52 in pre-market trading after gaining around 35% on Wednesday. CorePoint Lodging Inc. (NYSE: CPLG)...

The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.